The risk of developing a severe PE during short flights remains extremely low, because it occurs only once per million ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

Autolus Therapeutics plc , a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first Integrated ...

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...

A new study published in the International Journal of General Medicine showed that physicians may reliably estimate the ...

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...

Adults with type 2 diabetes and cancer who used a GLP-1 had a lower risk for death and hospitalization compared with adults ...

Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Dozens of felony cases have crumbled in DOJ's push to punish protesters South Carolina football player files criminal complaint after Texas state trooper shove White men feel something 'much deeper' ...

Learn how to rapidly identify, manage, and prevent drowning injuries using updated evidence-based approaches from prehospital care to ICU management.

New ACC/AHA guidelines provide updated management strategies for the growing population of adults living with congenital heart disease.